Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
REVENUES:        
Total revenues $ 17,830,590 $ 7,787,594 $ 33,879,208 $ 17,987,338
OPERATING EXPENSES:        
Cost of product revenue (exclusive of amortization expense shown below) 18,832,624 13,495,629 36,602,746 30,324,855
Research and development 1,158,866 1,656,420 2,146,515 3,185,158
Plasma center operating expenses 2,803,326 877,902 5,045,669 1,378,546
Amortization of intangible assets 178,838 178,838 357,676 357,676
Selling, general and administrative 10,438,168 8,702,630 20,472,083 16,634,714
Total operating expenses 33,411,822 24,911,419 64,624,689 51,880,949
LOSS FROM OPERATIONS (15,581,232) (17,123,825) (30,745,481) (33,893,611)
OTHER INCOME (EXPENSE):        
Interest income 5,926 19,411 27,985 267,479
Interest expense (3,246,680) (3,067,306) (6,442,430) (5,784,397)
Other expense (83,317) (6,371) (125,318) (12,792)
Other expense, net (3,324,071) (3,054,266) (6,539,763) (5,529,710)
NET LOSS $ (18,905,303) $ (20,178,091) $ (37,285,244) $ (39,423,321)
BASIC LOSS PER COMMON SHARE (in dollars per share) $ (0.15) $ (0.23) $ (0.31) $ (0.49)
DILUTED LOSS PER COMMON SHARE (in dollars per share) $ (0.15) $ (0.23) $ (0.31) $ (0.49)
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:        
Basic (in shares) 127,416,126 86,347,467 121,571,501 80,064,641
Diluted (in shares) 127,416,126 86,347,467 121,571,501 80,064,641
Product Revenue [Member]        
REVENUES:        
Total revenues $ 17,794,881 $ 7,751,885 $ 33,807,791 $ 17,915,921
License Revenue [Member]        
REVENUES:        
Total revenues $ 35,709 $ 35,709 $ 71,417 $ 71,417